Formulation has been with the Manufacturer for a long while now and was communicated officially by RAC 7-8 months ago they hoped it to be ready mid year. Damian recently quoted July.
Sounds like its still on track for delivery.
Clinical update
We still have 2 weeks as per qrtly for any offical ASX announcements.
an update in a letter to shareholders on this would have the same reaction as the quarterly did where they received feedback for not utilising PS info to the best effect. We can’t hammer them on it and then expect it in a letter to shareholders.
Let’s see in 2 weeks time.
Zantrene name change:
Highlights previous management commercial & possibly legal Inexperience, in protecting IP and especially bringing drugs to market.
Was Zantrene an under the radar ploy by accident?
Ann: Letter to Shareholders, page-14
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.92 |
Change
-0.025(1.29%) |
Mkt cap ! $331.3M | |||
| Open | High | Low | Value | Volume |
| $1.93 | $1.97 | $1.90 | $216.3K | 112.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11608 | $1.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.92 | 571 | 1 |
View Market Depth
| Last trade - 13.20pm 16/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |